Publications

PubMed | Google Scholar | Computer Science Bibliography (dblp)

(2023). The genomic and epigenomic landscape of double-negative metastatic prostate cancer. Cancer Research.

PDF DOI PubMed Journal

(2023). Beyond Reconstruction: What Leads to Satisfaction in Post-Disaster Recovery?. Journal of Happiness Studies.

Code Project DOI Journal

(2022). The 5-Hydroxymethylcytosine Landscape of Prostate Cancer. Cancer Research.

DOI PubMed Journal

(2021). Predicting Cancer Drug TARGETS - TreAtment Response GlmnET Signatures. NPJ genomic medicine.

DOI PubMed

(2021). An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer. Nature Communications.

PDF Dataset DOI PubMed Journal

(2021). Multiomics Characterization of Low-grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK-inhibitor Sensitivity and Therapeutic Vulnerability. Cancer Research.

PDF Dataset DOI Journal PubMed Dataset2

(2020). Autoantibody landscape in patients with advanced prostate cancer. Clinical Cancer Research.

DOI Journal PubMed

(2020). Identification of Conserved Evolutionary Trajectories in Tumors. Bioinformatics (ISMB 2020).

PDF Code DOI Journal PubMed

(2020). Well-Differentiated Papillary Mesothelioma of the Peritoneum is Genetically Distinct from Malignant Mesothelioma. Cancers.

PDF DOI Journal PubMed

(2020). Y-box Binding Protein-1 is Crucial in Acquired Drug Resistance Development in Metastatic Clear-Cell Renal Cell Carcinoma. Journal of Experimental & Clinical Cancer Research.

PDF DOI Journal PubMed

(2020). Identification of Predictive Gene Signature to Guide Precision Oncology of Clear-Cell Renal Cell Carcinoma. Scientific Reports.

PDF DOI Journal PubMed

(2020). Pathway and network analysis of more than 2,500 whole cancer genomes. Nature Communications.

PDF DOI Journal PubMed

(2019). BAP1 Haploinsufficiency Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma. Genome Medicine.

PDF Dataset DOI Journal PubMed Dataset2 Research Highlight

(2018). Computational prioritization of cancer driver genes for precision oncology. University of British Columbia (PhD Thesis).

PDF

(2018). High-throughput detection of RNA processing in bacteria. BMC Genomics.

DOI Journal PubMed

(2018). Deep Genomic Signature for early metastasis prediction in Prostate Cancer. (in submission).

DOI Preprint

(2018). Ultra High-Dimensional Nonlinear Feature Selection for Big Biological Data. IEEE Transactions on Knowledge and Data Engineering.

DOI Journal

(2017). HIT'nDRIVE: Patient-Specific Multi-Driver Gene Prioritization for Precision Oncology. Genome Research.

PDF Code Slides Video DOI Journal PubMed Video2 Blurb

(2016). BIRC6-targeting as potential therapy for advanced, enzalutamide-resistant prostate cancer. Clinical Cancer Research.

DOI Journal PubMed

(2014). Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer. Genome Biology.

PDF DOI Journal PubMed

(2014). A Meta-Analysis Approach for Characterizing Pan-Cancer Mechanisms of Drug Sensitivity in Cell Lines. PLoS ONE.

DOI Journal PubMed

(2014). HIT'nDRIVE: Multi-driver gene prioritization based on hitting time. RECOMB-2014.

PDF Code Video DOI Journal